company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6461000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6461000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6461000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18001000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14641000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14633000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1098000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13535000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13535000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-78000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13457000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11106000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.35
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11106000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.35
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,10000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.35
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6595000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6595000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6595000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4832000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31187000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36019000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29424000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,29000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29399000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,203000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-145000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29051000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.76
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.76
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11282000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,2012-08-14 11:41:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.76
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8582000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8582000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8582000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3306000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23913000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27219000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18637000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,6000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18631000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-93000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-125000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18599000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.81
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.81
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11389000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,2012-11-14 12:06:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.81
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12577000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12577000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12577000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3215000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27529000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30744000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18167000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18163000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-58000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18221000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18221000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-105000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18116000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.75
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.75
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.75
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11344000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11344000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11344000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3728000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31651000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35379000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24035000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,9000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24027000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,625000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23402000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23402000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-118000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23284000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,10900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.14
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,10900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.14
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11846000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q1,2012-01-01,2012-03-31,2013-05-13 12:26:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.14
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3610000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28758000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32368000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20305000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,54000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,54000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-20251000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,112000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-20139000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-20139000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-113000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-20026000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,90581000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q2,2012-04-01,2012-06-30,2013-08-08 13:10:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4312000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30885000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35197000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23874000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,64000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23810000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,490000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-121000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-23199000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q3,2012-07-01,2012-09-30,2013-11-08 13:55:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14191000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14191000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14191000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4155000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,34564000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,38719000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24528000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,552000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,57000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-495000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25023000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,130000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24893000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24893000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-125000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24768000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72831000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14655000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14655000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14655000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4932000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41921000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27266000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1220000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1168000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28434000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,111000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-170000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-28153000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95879000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5095000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42465000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47560000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29108000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1293000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1258000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30366000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,115000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30251000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30251000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-169000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30082000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,97000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,97000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,96170000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 16:02:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6856000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6856000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6856000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5150000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37630000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42780000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35924000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3946000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,36000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3910000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39834000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,71000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39763000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39763000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-132000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-39631000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,101600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,101600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101155000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 17:11:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7823000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7823000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7823000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6010000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30055000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36065000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28242000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4479000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4436000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32678000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,330000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32348000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32348000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,711000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33059000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,99200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,99200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98919000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13034000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13034000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13034000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6224000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30324000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36548000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23514000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4511000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,35000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4476000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-27990000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,236000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27754000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27754000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-169000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27585000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,102200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,102200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,102888000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,27815000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,27815000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27815000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7921000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,33795000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41716000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4570000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4550000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18451000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,161000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-181000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18109000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,103809000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 17:13:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28002000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28002000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28002000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8095000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43632000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51727000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-23725000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4585000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4578000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28303000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,265000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-137000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-27901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,103300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,103300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104871000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 17:07:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33905000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33905000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33905000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8277000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30744000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39021000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5116000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4564000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,52000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4512000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9628000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,151000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9477000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9477000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,219000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9696000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104410000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14842000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14842000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14842000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9189000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35679000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44868000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-30026000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4566000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,47000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4519000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-34545000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,113000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34432000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34432000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,327000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-34759000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107148000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36558000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36558000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36558000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12315000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42806000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55121000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18563000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4482000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,34000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4448000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-23011000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,110000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-123000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22778000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,108500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,108500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,109975000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,2016-08-04 17:11:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16440000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16440000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16440000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,16956000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,37763000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54719000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38279000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4476000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4463000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-42742000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,356000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42386000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42386000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,208000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-42594000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,112100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,112100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,112417000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 17:20:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,-67840000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,-67840000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,-67840000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,-14412000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4785000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,-9627000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-58213000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5245000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,5000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,917000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-62536000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-11215000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-579000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3832000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48068000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-242000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-47826000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,11100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,11100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,11136000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.31
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28002000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34454000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34454000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,72000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3218000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37672000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-43000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37715000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-943000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38658000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-185000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38473000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,116600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,116600000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,116064000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8138000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27695000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15858000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,122000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15736000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-51633000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-64000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51633000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,675000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50958000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-208000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-50750000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,126900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,126900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,126161000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:29:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6448000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28247000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,809000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35504000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-35504000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1560000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,385000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1111000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-36615000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9770000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26845000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-3430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30275000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-207000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30068000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12921000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,2017-11-08 11:49:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11014000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25621000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41536000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41536000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1741000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-385000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2108000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43588000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3454000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,99000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40091000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,6464000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33627000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1178000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-32449000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.6
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.6
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,12533000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.6
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5634000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27239000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27239000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1979000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1967000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-29206000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29206000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-947000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30153000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-467000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-29686000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13059000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.27
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,14798000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19751000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34549000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-34549000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26762000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,382000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-25336000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59885000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-30239000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29646000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,540485000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,510839000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,511563000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,38.62
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,38.62
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13246000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,38.62
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,2018-08-07 08:01:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,10.55
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3366000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13598000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16964000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1659000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11098000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,69000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,9508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7456000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2133000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,8456000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3133000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,31000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,12900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,12900000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13282000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,2018-11-07 09:01:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4654000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12360000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17014000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17014000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4250000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,249000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-841000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4842000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21856000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10027000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11829000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,-1122000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12951000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12951000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.98
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.98
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13232000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.98
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4270000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13106000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17376000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17376000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,275000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-681000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-406000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3513000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13678000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17191000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17191000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,282000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-860000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-578000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,2019-07-17 07:01:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.33
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3777000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12959000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16736000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16736000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,472000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,306000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-237000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-403000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17139000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4798000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12341000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,16330000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.3
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.3
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:16:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.3
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4041000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10231000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14272000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14272000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,484000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,436000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15772000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2897000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12875000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,3931000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8944000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8944000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.67
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.67
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.67
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3683000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6361000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10044000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,478000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,365000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-301000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-414000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.78
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13343000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5929000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4739000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1410000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9258000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9258000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1049000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,207000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,670000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-172000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,13300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.71
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,13300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.71
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,13344000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,2019-07-17 07:01:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.71
